Pakistani pharmaceutical firm Highnoon Laboratories Limited (PSX: HINOON) Tuesday announced that it has entered into a ...

Highnoon Laboratories Limited (HINOON), a Pakistani pharmaceutical company, has announced a strategic partnership with Beximco Pharmaceuticals Limited, a leading Bangladesh-based drug manufacturer, to ...

Beximco Group The drug maker is now lending its expertise to a global initiative to ensure sufficient supply of drugs to fight the virus. In November 2020, it joined Medicines Patent Pool, a ...

The Beximco Group plays a key role in supporting the Construction, Marine and Process (CMP) sectors in Singapore. Covid-19 has had and continues to have a devastating impact on the livelihoods of ...

Beximco said it doesn’t expect sales of generic molnupiravir to significantly boost revenues, given currently low COVID-19 infections in Bangladesh, which neighbours India.

Bangladesh's Beximco Pharmaceuticals (BXPH.DH) will buy up to 3 million doses of the AstraZeneca (AZN.L) vaccine from Serum Institute of India at about $8 each for sale on the private market ...

Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP) has released an update.Beximco Pharmaceuticals Limited has announced the adjournment of a full-court hearing related to a writ petition ...

But, Beximco failed in the very first hurdle: as of October 18 it has paid only Tk 34.50 crore against the three quarters' due of Tk 94.68 crore, according to data from Sonali.

Beximco has sought support from the government to extend the repayment period of its liabilities to Janata Bank over the next 10 years, including a two-year moratorium. On September 19, the ...

Shares in Beximco Pharmaceuticals Ltd. fell Tuesday after it said that it expects a coronavirus-related hit to its full-year 2020 sales growth and profitability, though its third-quarter revenue ...

Beximco said it doesn't expect sales of generic molnupiravir to significantly boost revenues, given currently low COVID-19 infections in Bangladesh, which neighbours India.

Bangladesh's Beximco Pharmaceuticals will buy up to 3 million doses of the AstraZeneca COVID-19 vaccine from Serum Institute of India at about $8 each for sale on the private market, Beximco's ...